These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35241286)

  • 1. Cryoprecipitate use during massive transfusion: A propensity score analysis.
    Fleming AM; Shah KS; Byerly SE; Magnotti LJ; Fischer PE; Seger CP; Kerwin AJ; Croce MA; Howley IW
    Injury; 2022 Jun; 53(6):1972-1978. PubMed ID: 35241286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cryoprecipitate Use With Survival After Major Trauma in Children Receiving Massive Transfusion.
    Tama MA; Stone ME; Blumberg SM; Reddy SH; Conway EE; Meltzer JA
    JAMA Surg; 2021 May; 156(5):453-460. PubMed ID: 33595600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryoprecipitate use in the PROMMTT study.
    Holcomb JB; Fox EE; Zhang X; White N; Wade CE; Cotton BA; del Junco DJ; Bulger EM; Cohen MJ; Schreiber MA; Myers JG; Brasel KJ; Phelan HA; Alarcon LH; Muskat P; Rahbar MH;
    J Trauma Acute Care Surg; 2013 Jul; 75(1 Suppl 1):S31-9. PubMed ID: 23778509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofibrinogenemic Massive Transfusion Trauma Patients Experience Worse Outcomes.
    Parker MJ; Crowder EW; Miles MVP; Harrell KN; Maxwell RA
    Am Surg; 2023 Aug; 89(8):3423-3428. PubMed ID: 36908225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cryoprecipitate in massively transfused patients: Results from the Trauma Quality Improvement Program database may change your mind.
    Ditillo M; Hanna K; Castanon L; Zeeshan M; Kulvatunyou N; Tang A; Sakran J; Gries L; Joseph B
    J Trauma Acute Care Surg; 2020 Aug; 89(2):336-343. PubMed ID: 32355101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryoprecipitate administration after trauma.
    Olaussen A; Fitzgerald MC; Tan GA; Mitra B
    Eur J Emerg Med; 2016 Aug; 23(4):269-273. PubMed ID: 25734480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric Cryoprecipitate Transfusion in Patients with Severe Hemorrhage: Results from the US Experience in the International CRYOSTAT-2 Trial.
    Van Gent JM; Kaminski CW; Praestholm C; Pivalizza EG; Clements TW; Kao LS; Stanworth S; Brohi K; Cotton BA
    J Am Coll Surg; 2024 Apr; 238(4):636-643. PubMed ID: 38146823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Mortality with Cryoprecipitate During Massive Transfusion in Penetrating but Not Blunt Trauma.
    Gaitanidis A; Sinyard RT; Nederpelt CJ; Maurer LR; Christensen MA; Mashbari H; Velmahos GC; Kaafarani HMA
    J Surg Res; 2022 Jan; 269():94-102. PubMed ID: 34537533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients.
    Shaz BH; Dente CJ; Nicholas J; MacLeod JB; Young AN; Easley K; Ling Q; Harris RS; Hillyer CD
    Transfusion; 2010 Feb; 50(2):493-500. PubMed ID: 19804568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted cryoprecipitate transfusion in severe traumatic haemorrhage.
    Ho D; Chan E; Campbell D; Wake E; Walters K; Bulmer AC; McCullough J; Wullschleger M; Winearls J
    Injury; 2020 Sep; 51(9):1949-1955. PubMed ID: 32553426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant factor VIIa in US military casualties for a five-year period.
    Wade CE; Eastridge BJ; Jones JA; West SA; Spinella PC; Perkins JG; Dubick MA; Blackbourne LH; Holcomb JB
    J Trauma; 2010 Aug; 69(2):353-9. PubMed ID: 20699744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
    Perkins JG; Schreiber MA; Wade CE; Holcomb JB
    J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of therapeutic strategies for bleeding injury on early survival, transfusion needs and correction of coagulopathy.
    Balvers K; van Dieren S; Baksaas-Aasen K; Gaarder C; Brohi K; Eaglestone S; Stanworth S; Johansson PI; Ostrowski SR; Stensballe J; Maegele M; Goslings JC; Juffermans NP;
    Br J Surg; 2017 Feb; 104(3):222-229. PubMed ID: 28079258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the bleeding trauma patient: predictive factors for massive transfusion in an Australasian trauma population.
    Hsu JM; Hitos K; Fletcher JP
    J Trauma Acute Care Surg; 2013 Sep; 75(3):359-64. PubMed ID: 24089108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes After Massive Transfusion in Trauma Patients: Variability Among Trauma Centers.
    Hamidi M; Zeeshan M; Kulvatunyou N; Adun E; O'Keeffe T; Zakaria ER; Gries L; Joseph B
    J Surg Res; 2019 Feb; 234():110-115. PubMed ID: 30527461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive transfusion exceeding 50 units of blood products in trauma patients.
    Vaslef SN; Knudsen NW; Neligan PJ; Sebastian MW
    J Trauma; 2002 Aug; 53(2):291-5; discussion 295-6. PubMed ID: 12169936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of fibrinogen concentrate is associated with improved survival among severe trauma patients: a single-centre propensity score-matched analysis.
    Itagaki Y; Hayakawa M; Maekawa K; Saito T; Kodate A; Honma Y; Mizugaki A; Yoshida T; Ohyasu T; Katabami K; Wada T
    World J Emerg Surg; 2020; 15():7. PubMed ID: 31956337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial.
    Davenport R; Curry N; Fox EE; Thomas H; Lucas J; Evans A; Shanmugaranjan S; Sharma R; Deary A; Edwards A; Green L; Wade CE; Benger JR; Cotton BA; Stanworth SJ; Brohi K;
    JAMA; 2023 Nov; 330(19):1882-1891. PubMed ID: 37824155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital.
    Stinger HK; Spinella PC; Perkins JG; Grathwohl KW; Salinas J; Martini WZ; Hess JR; Dubick MA; Simon CD; Beekley AC; Wolf SE; Wade CE; Holcomb JB
    J Trauma; 2008 Feb; 64(2 Suppl):S79-85; discussion S85. PubMed ID: 18376176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early hemostasis strategy on secondary post-traumatic sepsis in trauma hemorrhagic patients.
    Shang W; Cao Y; Li Y; Ma M; Che H; Xiao P; Yu Y; Kang H; Wang D
    Injury; 2024 Feb; 55(2):111205. PubMed ID: 38006781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.